CHD and periodontitis
This article was originally published in The Tan Sheet
Executive Summary
There is a "strong and statistically significant association between periodontal pathogen burden" and coronary heart disease, according to a case-controlled study in the Archives of Internal Medicine March 13. The study included 263 patients with confirmed, stable CHD and 526 matched controls, Axel Spahr, DDS, University of Ulm Medical Center, Germany, et al., state. Main outcome measures included total periodontal pathogen burden, number of the various periodontal pathogens and study participants' need for periodontal treatment...
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.